371 related articles for article (PubMed ID: 29409536)
21. New insight into praziquantel against various developmental stages of schistosomes.
Wu W; Wang W; Huang YX
Parasitol Res; 2011 Dec; 109(6):1501-7. PubMed ID: 21984370
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and biological evaluation of praziquantel and endoperoxide conjugates as antischistosomal agents.
Yang JJ; Boissier J; Chen JL; Yao H; Yang S; Rognon A; Qiao C
Future Med Chem; 2015; 7(6):713-25. PubMed ID: 25996065
[TBL] [Abstract][Full Text] [Related]
23. Is there a reduced sensitivity of dihydroartemisinin against praziquantel-resistant Schistosoma japonicum?
Wang W; Li HJ; Qu GL; Xing YT; Yang ZK; Dai JR; Liang YS
Parasitol Res; 2014 Jan; 113(1):223-8. PubMed ID: 24146208
[TBL] [Abstract][Full Text] [Related]
24. Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis.
Alwan SN; Taylor AB; Rhodes J; Tidwell M; McHardy SF; LoVerde PT
PLoS Pathog; 2023 Jul; 19(7):e1011018. PubMed ID: 37428793
[TBL] [Abstract][Full Text] [Related]
25. [Observations on the histopathological changes of Schistosoma japonicum and host liver caused by pyquiton in experimental chemotherapy (author's transl)].
Yang YQ; Yang HZ; Xiao SH; Shao BR; Tang XM; Zhu ZG; Zhang HX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1979 Sep; 1(1):7-12. PubMed ID: 262815
[No Abstract] [Full Text] [Related]
26. Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine.
da Silva VBR; Campos BRKL; de Oliveira JF; Decout JL; do Carmo Alves de Lima M
Bioorg Med Chem; 2017 Jul; 25(13):3259-3277. PubMed ID: 28495384
[TBL] [Abstract][Full Text] [Related]
27. Schistosoma japonicum calcium-binding tegumental protein SjTP22.4 immunization confers praziquantel schistosomulumicide and antifecundity effect in mice.
Zhang Z; Xu H; Gan W; Zeng S; Hu X
Vaccine; 2012 Jul; 30(34):5141-50. PubMed ID: 22683520
[TBL] [Abstract][Full Text] [Related]
28. Praziquantel derivatives with antischistosomal activity: aromatic ring modification.
Wang ZX; Chen JL; Qiao C
Chem Biol Drug Des; 2013 Aug; 82(2):216-25. PubMed ID: 23617439
[TBL] [Abstract][Full Text] [Related]
29. An iterative process produces oxamniquine derivatives that kill the major species of schistosomes infecting humans.
Guzman MA; Rugel AR; Tarpley RS; Alwan SN; Chevalier FD; Kovalskyy DP; Cao X; Holloway SP; Anderson TJC; Taylor AB; McHardy SF; LoVerde PT
PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008517. PubMed ID: 32810153
[TBL] [Abstract][Full Text] [Related]
30. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
Liu LX; Li-Li J; Qiong C; Xiao-Lin F
Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
[TBL] [Abstract][Full Text] [Related]
31. A comparison of the antischistosomal effect of levo- and dextro-praziquantel on Schistosoma japonicum and S. mansoni in mice.
Tanaka M; Ohmae H; Utsunomiya H; Nara T; Irie Y; Yasuraoka K
Am J Trop Med Hyg; 1989 Aug; 41(2):198-203. PubMed ID: 2505624
[TBL] [Abstract][Full Text] [Related]
32. Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems.
Guidi A; Lalli C; Perlas E; Bolasco G; Nibbio M; Monteagudo E; Bresciani A; Ruberti G
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004928. PubMed ID: 27518281
[TBL] [Abstract][Full Text] [Related]
33. [Study progress on the mode of action of praziquantel against schistosomes].
Xiao SH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Dec; 25(6):492-502. PubMed ID: 18441900
[TBL] [Abstract][Full Text] [Related]
34. Response of drug resistant isolates of Schistosoma mansoni to antischistosomal agents.
Drescher KM; Rogers EJ; Bruce JI; Katz N; Dias LC; Coles GC
Mem Inst Oswaldo Cruz; 1993; 88(1):89-95. PubMed ID: 8246759
[TBL] [Abstract][Full Text] [Related]
35. Praziquantel: a new hope for schistosomiasis.
Lancet; 1980 Mar; 1(8169):635-6. PubMed ID: 6102634
[No Abstract] [Full Text] [Related]
36. In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium.
Kovač J; Vargas M; Keiser J
Parasit Vectors; 2017 Aug; 10(1):365. PubMed ID: 28764732
[TBL] [Abstract][Full Text] [Related]
37. Mefloquine--an aminoalcohol with promising antischistosomal properties in mice.
Keiser J; Chollet J; Xiao SH; Mei JY; Jiao PY; Utzinger J; Tanner M
PLoS Negl Trop Dis; 2009; 3(1):e350. PubMed ID: 19125172
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical Investigations of Treatment with Ro 13-3978, Praziquantel, Oxamniquine, and Mefloquine in Schistosoma mansoni-Infected Mice.
Panic G; Ruf MT; Keiser J
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971860
[TBL] [Abstract][Full Text] [Related]
39. The effect of praziquantel on Schistosoma haematobium, S. japonicum and S. mansoni in primates.
Webbe G; James C; Nelson GS; Sturrock RF
Arzneimittelforschung; 1981; 31(3a):542-4. PubMed ID: 7195244
[TBL] [Abstract][Full Text] [Related]
40. Differential impact of mass and targeted praziquantel delivery on schistosomiasis control in school-aged children: A systematic review and meta-analysis.
Cribb DM; Clarke NE; Doi SAR; Vaz Nery S
PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007808. PubMed ID: 31603895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
